Literature DB >> 1610364

20-Hydroxyeicosatetraenoic acid is excreted as a glucuronide conjugate in human urine.

C Prakash1, J Y Zhang, J R Falck, K Chauhan, I A Blair.   

Abstract

20-hydroxyeicosatetraenoic acid, a major renal P-450 metabolite of arachidonic acid, has been quantified in human urine using capillary gas chromatography/electron capture negative ion chemical ionization mass spectrometry. The urinary excretion of 20-hydroxyeicosatetraenoic acid was in the low pg/ml range. However, treatment of urine with beta-glucuronidase resulted in a 13- to 28-fold increase in its concentration. This suggests 20-hydroxyeicosatetraenoic acid differs from other eicosanoids in that it is excreted primarily as a glucuronide conjugate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610364     DOI: 10.1016/0006-291x(92)91686-k

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE.

Authors:  D Sacerdoti; M Balazy; P Angeli; A Gatta; J C McGiff
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.

Authors:  V R Holla; F Adas; J D Imig; X Zhao; E Price; N Olsen; W J Kovacs; M A Magnuson; D S Keeney; M D Breyer; J R Falck; M R Waterman; J H Capdevila
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  The arachidonic acid monooxygenase: from biochemical curiosity to physiological/pathophysiological significance.

Authors:  Jorge H Capdevila; John R Falck
Journal:  J Lipid Res       Date:  2018-08-28       Impact factor: 5.922

4.  Quantification of 20-hydroxyeicosatetraenoic acid by colorimetric competitive enzyme linked immunosorbent assay.

Authors:  Harry E Grates; Richard M McGowen; Smiti V Gupta; John R Falck; Thomas R Brown; Denis M Callewaert; Diane M Sasaki
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

5.  Convenient syntheses of [20,20,20-H(3)]-arachidonic acid and [20,20-H(2)]-20-hydroxyeicosatetraenoic acid.

Authors:  J R Falck; Siddam Anjaiah; Venugopal Raju Tuniki; V Raj Gopal; Jorge H Capdevila
Journal:  J Labelled Comp Radiopharm       Date:  2006-03       Impact factor: 1.921

6.  20-HETE mediates ozone-induced, neutrophil-independent airway hyper-responsiveness in mice.

Authors:  Philip R Cooper; A Clementina Mesaros; Jie Zhang; Peter Christmas; Christopher M Stark; Karim Douaidy; Michael A Mittelman; Roy J Soberman; Ian A Blair; Reynold A Panettieri
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

Review 7.  Targeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography-tandem mass spectrometry.

Authors:  Clementina Mesaros; Seon Hwa Lee; Ian A Blair
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-17       Impact factor: 3.205

8.  20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR.

Authors:  Üzen Savas; Shouzou Wei; Mei-Hui Hsu; John R Falck; F Peter Guengerich; Jorge H Capdevila; Eric F Johnson
Journal:  J Biol Chem       Date:  2016-06-13       Impact factor: 5.157

9.  Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.

Authors:  Pietro Minuz; Houli Jiang; Cristiano Fava; Lucia Turolo; Stefania Tacconelli; Marco Ricci; Paola Patrignani; Alberto Morganti; Alessandro Lechi; John C McGiff
Journal:  Hypertension       Date:  2008-03-31       Impact factor: 10.190

Review 10.  Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).

Authors:  Kathleen M Knights; Andrew Rowland; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.